A recent Center for Public Integrity study revealed that manufacturers of pharmaceuticals, medical devices, and other health products spent nearly $182 million on federal lobbying from January 2005 through June 2006. Much of the money has been spent to quell the antagonism the pharmaceutical companies face in the Democratically-controlled Congress. One effort by the lawmakers that drew heavy drug industry lobbying was to undo a provision of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003. The drug industry also lobbied forcefully to halt legislation that would have allowed drugs to be imported from other countries and sold in the United States.
For the full report.